1. Market Research
  2. > Biotechnology
  3. > Biological Therapy Market Trends
  4. > Biological Therapy Analysis & Statistics, July 2016

Biological Therapy Analysis & Statistics, July 2016

24/7 Customer Support

Talk to Veronica

+1 718 514 2762

1-30 of about 900 reports

Purchase Reports From Reputable Market Research Publishers

Retinitis Pigmentosa (Retinitis) - Pipeline Review, H1 2016

Retinitis Pigmentosa (Retinitis) - Pipeline Review, H1 2016

  • $ 42 529
  • Company report
  • June 2016
  • by Global Markets Direct

Retinitis Pigmentosa (Retinitis) - Pipeline Review, H1 2016 Summary Global Markets Direct’s, ‘Retinitis Pigmentosa (Retinitis) - Pipeline Review, H1 2016’, provides an overview of the Retinitis Pigmentosa ...

  • Industries : Therapy, Pathology, Research and Development, Biological Therapy
  • Countries : United States
Sangamo BioSciences, Inc. - Product Pipeline Review - 2016

Sangamo BioSciences, Inc. - Product Pipeline Review - 2016

  • $ 42 529
  • Company report
  • June 2016
  • by Global Markets Direct

Sangamo BioSciences, Inc. - Product Pipeline Review - 2016 Summary Global Markets Direct’s, ‘Sangamo BioSciences, Inc. - Product Pipeline Review - 2016’, provides an overview of the Sangamo BioSciences, ...

  • Industries : Research and Development, Biological Therapy, Therapy, Pathology
  • Countries : United States
Mucopolysaccharidosis III (MPS III) (Sanfilippo Syndrome ) - Pipeline Review, H1 2016

Mucopolysaccharidosis III (MPS III) (Sanfilippo Syndrome ) - Pipeline Review, H1 2016

  • $ 42 529
  • Company report
  • June 2016
  • by Global Markets Direct

Mucopolysaccharidosis III (MPS III) (Sanfilippo Syndrome ) - Pipeline Review, H1 2016 Summary Global Markets Direct’s, ‘Mucopolysaccharidosis III (MPS III) (Sanfilippo Syndrome ) - Pipeline Review, ...

  • Industries : Pathology, Therapy, Pharmaceutical, Healthcare
  • Countries : United States
Mucopolysaccharidosis I (MPS I) (Hurler Syndrome ) - Pipeline Review, H1 2016

Mucopolysaccharidosis I (MPS I) (Hurler Syndrome ) - Pipeline Review, H1 2016

  • $ 42 529
  • Company report
  • June 2016
  • by Global Markets Direct

Mucopolysaccharidosis I (MPS I) (Hurler Syndrome ) - Pipeline Review, H1 2016 Summary Global Markets Direct’s, ‘Mucopolysaccharidosis I (MPS I) (Hurler Syndrome ) - Pipeline Review, H1 2016’, provides ...

  • Industries : Pathology, Therapy, Healthcare, Pharmaceutical
  • Countries : United States
Type 1 diabetes (Juvenile Diabetes) - Pipeline Review, H1 2016

Type 1 diabetes (Juvenile Diabetes) - Pipeline Review, H1 2016

  • $ 42 529
  • Company report
  • June 2016
  • by Global Markets Direct

Type 1 diabetes (Juvenile Diabetes) - Pipeline Review, H1 2016 Summary Global Markets Direct’s, ‘Type 1 Diabetes (Juvenile Diabetes) - Pipeline Review, H1 2016’, provides an overview of the Type ...

  • Industries : Chronic Disease, Pathology
  • Countries : United States
Liver Failure (Hepatic Insufficiency) - Pipeline Review, H1 2016

Liver Failure (Hepatic Insufficiency) - Pipeline Review, H1 2016

  • $ 42 529
  • Company report
  • June 2016
  • by Global Markets Direct

Liver Failure (Hepatic Insufficiency) - Pipeline Review, H1 2016 Summary Global Markets Direct’s, ‘Liver Failure (Hepatic Insufficiency) - Pipeline Review, H1 2016’, provides an overview of the Live ...

  • Industries : Pathology, Therapy, Pharmaceutical
  • Countries : United States
Age Related Macular Degeneration - Pipeline Review, H1 2016

Age Related Macular Degeneration - Pipeline Review, H1 2016

  • $ 42 521
  • Company report
  • May 2016
  • by Global Markets Direct

Age Related Macular Degeneration - Pipeline Review, H1 2016 Summary Global Markets Direct’s, ‘Age Related Macular Degeneration - Pipeline Review, H1 2016’, provides an overview of the Age Related ...

  • Industries : Pathology, General Medicine and Specialty Medicine, Healthcare
  • Countries : United States
Cervical Intraepithelial Neoplasia (CIN) - Pipeline Review, H1 2016

Cervical Intraepithelial Neoplasia (CIN) - Pipeline Review, H1 2016

  • $ 42 521
  • Company report
  • May 2016
  • by Global Markets Direct

Cervical Intraepithelial Neoplasia (CIN) - Pipeline Review, H1 2016 Summary Global Markets Direct’s, ‘Cervical Intraepithelial Neoplasia (CIN) - Pipeline Review, H1 2016’, provides an overview of ...

  • Industries : Therapy, Biopharmaceutical, Biological Therapy, Biotechnology
  • Countries : United States
Metachromatic Leukodystrophy (MLD) - Pipeline Review, H1 2016

Metachromatic Leukodystrophy (MLD) - Pipeline Review, H1 2016

  • $ 42 521
  • Company report
  • May 2016
  • by Global Markets Direct

Metachromatic Leukodystrophy (MLD) - Pipeline Review, H1 2016 Summary Global Markets Direct’s, ‘Metachromatic Leukodystrophy (MLD) - Pipeline Review, H1 2016’, provides an overview of the Metachromatic ...

  • Industries : Mental Health
  • Countries : United States, World
Immuno-Oncology Strategic Insight - Multi-Indication And Market Size Analysis

Immuno-Oncology Strategic Insight - Multi-Indication And Market Size Analysis

  • $ 9 495
  • Industry report
  • May 2016
  • by Global Data

Immuno-Oncology Strategic Insight - Multi-Indication And Market Size Analysis Summary GlobalData estimates that the total IO market will be worth approximately $14 billion in 2019, rising to $34 billion ...

  • Industries : Therapy, Cancer, Pathology, Pharmaceutical, Biotechnology
The Global Market for Stem Cells

The Global Market for Stem Cells

  • $ 6 650
  • Industry report
  • May 2016
  • by BCC Research

This BCC Research report provides implications of stem cell research and commercial trends in the context of the current size and growth of the pharmaceutical market, both in global terms and important ...

  • Industries : Biological Therapy
  • Countries : World
Stem Cell Banking Market by Bank Type, Service, Application, Region - Forecast to 2021

Stem Cell Banking Market by Bank Type, Service, Application, Region - Forecast to 2021

  • $ 5 650
  • Industry report
  • July 2016
  • by MarketsandMarkets

The global stem cell banking market is expected to reach USD 3.96 billion by 2021 from USD 1.58 billion in 2016, at a CAGR of 20.2% from 2016 to 2021. The storage services segment is expected to contribute ...

  • Industries : Biological Therapy, Biotechnology, Banking, Financial Services
  • Countries : World, North America
Regenerative Medicines Market by Therapy, Product, Application, Region - Global Forecast to 2021

Regenerative Medicines Market by Therapy, Product, Application, Region - Global Forecast to 2021

  • $ 5 650
  • Industry report
  • July 2016
  • by MarketsandMarkets

The global regenerative medicines market is expected to reach USD 49.41 billion by 2021 from USD 17.06 billion in 2016, at a CAGR of 23.7% during the period of 2016-2021. The global regenerative medicines ...

  • Industries : Biological Therapy, Biotechnology, Genomics
  • Countries : World, Europe, North America
3D Cell Culture Market by Technology, Application, End-Users and Geography- Global Forecast to 2021

3D Cell Culture Market by Technology, Application, End-Users and Geography- Global Forecast to 2021

  • $ 5 650
  • Industry report
  • July 2016
  • by MarketsandMarkets

The global 3D cell culture market size is expected to reach USD 1345.2 million by 2021 from USD 466.8 million in 2016, at a CAGR of 23.6%. The global 3D cell culture market is segmented based on technology, ...

  • Industries : Biological Therapy, In Vitro Diagnostics, Biotechnology, Medical Device
  • Countries : World, North America, Europe
Cell Expansion Market by Product , Cell Type , Application , End user  - Global Forecasts to 2021

Cell Expansion Market by Product , Cell Type , Application , End user - Global Forecasts to 2021

  • $ 5 650
  • Industry report
  • June 2016
  • by MarketsandMarkets

The cell expansion market is expected to reach USD 18.76 billion by 2021 from USD 8.34 billion in 2016 at a CAGR of 17.6%. The global cell expansion market is segmented based on product, cell type, application, ...

  • Industries : Biological Therapy, Biotechnology
  • Countries : World, Europe, Asia, North America
US Market Report for Prostate Cancer Treatment Devices 2016 - MedCore

US Market Report for Prostate Cancer Treatment Devices 2016 - MedCore

  • $ 4 995
  • Industry report
  • July 2016
  • by iData Research, Inc.

Unlike other cancer treatments, brachytherapy has a history that spans over a century. In 1901, Pierre Curie, a physicist from France, first suggested that radiation could be used to treat cancer to one ...

  • Industries : Biological Therapy
  • Countries : United States
Future of Cell Therapy in the Regenerative Medicine Market 

Future of Cell Therapy in the Regenerative Medicine Market 

  • $ 4 950
  • Industry report
  • May 2016
  • by Frost & Sullivan

Future of Cell Therapy in the Regenerative Medicine Market : Combination Therapies and Advanced Manufacturing Techniques are the New Criteria Shaping the $4 Billion Market This Frost & Sullivan research ...

  • Industries : Biological Therapy
Stem Cell Therapy - Global Market Outlook (2015-2022)

Stem Cell Therapy - Global Market Outlook (2015-2022)

  • $ 4 157
  • Industry report
  • May 2016
  • by Stratistics MRC

According to Stratistics MRC, the stem cell therapy market is expected to grow at a CAGR of 37.6% during the forecast period 2015 to 2022. Rising awareness about stem cell therapies is the key factor driving ...

  • Industries : Biological Therapy
  • Countries : World, North America, Asia, Europe
Stem Cells Market Analysis By Product (Adult Stem Cells, Human Embryonic Cells, Pluripotent Stem Cells), By Application (Regenerative Medicine, Drug Discovery and Development) And Segment Forecasts To 2020

Stem Cells Market Analysis By Product (Adult Stem Cells, Human Embryonic Cells, Pluripotent Stem Cells), By Application (Regenerative Medicine, Drug Discovery and Development) And Segment Forecasts To 2020

  • $ 4 700
  • Industry report
  • May 2016
  • by Grand View Research

The global market for stem cells is expected to reach USD 170.15 billion by 2020. Growing prevalence of chronic diseases such as cardiovascular and liver disease, diabetes and cancer coupled with the presence ...

  • Industries : Biological Therapy
  • Countries : World
Bovine FGF Chemical Report

Bovine FGF Chemical Report

  • $ 4 609
  • Industry report
  • June 2016
  • by PureData

Bovine FGF Chemical Report This Bovine FGF Chemical World Consumption Reportt provides data on the net consumption of Bovine FGF in each of the countries listed. The substance covered (Bovine FGF) are ...

  • Industries : Biological Therapy
  • Countries : World
Global Prostate Cancer Therapeutics Industry

Global Prostate Cancer Therapeutics Industry

  • $ 4 500
  • Industry report
  • May 2016
  • by Global Industry Analysts

This report analyzes the worldwide markets for Prostate Cancer Therapeutics in US$ Million by the following Segments: Hormone Therapy, and Other Therapies. The report provides separate comprehensive analytics ...

  • Industries : Cancer, Pathology, Therapy
  • Countries : World, Europe, Canada
Global Stem Cell Therapy Market Analysis & Trends - Industry Forecast to 2025

Global Stem Cell Therapy Market Analysis & Trends - Industry Forecast to 2025

  • $ 4 200
  • Industry report
  • June 2016
  • by Accuray Research LLP

The Global Stem Cell Therapy Market is poised to grow at a CAGR of around 37.3% over the next decade to reach approximately $1.87 billion by 2025. This industry report analyzes the global markets for Stem ...

  • Industries : Biological Therapy
  • Countries : World, Europe, Asia, North America
Pneumonia Treatment Drugs Markets in China

Pneumonia Treatment Drugs Markets in China

  • $ 4 000
  • Industry report
  • May 2016
  • by Asia Market Information & Development Company

China's demand for Pneumonia Treatment Drugs has grown at a fast pace in the past decade. In the next decade, both production and demand will continue to grow. The Chinese economy maintains a high speed ...

  • Industries : Therapy, Pharmaceutical
  • Countries : China
Blood Disease Drugs Markets in China

Blood Disease Drugs Markets in China

  • $ 4 000
  • Industry report
  • May 2016
  • by Asia Market Information & Development Company

China's demand for Blood Disease Drugs has grown at a fast pace in the past decade. In the next decade, both production and demand will continue to grow. The Chinese economy maintains a high speed growth ...

  • Industries : Pathology, Therapy, Pharmaceutical, Healthcare, Chronic Disease, Medical Supply
  • Countries : China
Cell Surface Markers: US, Europe (France, Germany, Italy, Spain, UK), Japan--Competitive Strategies, Country Forecasts, Innovative Technologies, Emerging Opportunities

Cell Surface Markers: US, Europe (France, Germany, Italy, Spain, UK), Japan--Competitive Strategies, Country Forecasts, Innovative Technologies, Emerging Opportunities

  • $ 3 500
  • Industry report
  • June 2016
  • by Venture Planning Group

The use of surface marker identification and classification of cells is spreading beyond lymphocytes to the identification of monocytes, macrophages, myeloid stem cells, and tumor cells. A synergistic ...

  • Industries : Biological Therapy
  • Countries : Spain, France, Italy, United Kingdom, Japan
Fibroblast Growth Factor 2 (Basic Fibroblast Growth Factor or Heparin Binding Growth Factor 2 or FGF-2 or bFGF) - Pipeline Review, H1 2016

Fibroblast Growth Factor 2 (Basic Fibroblast Growth Factor or Heparin Binding Growth Factor 2 or FGF-2 or bFGF) - Pipeline Review, H1 2016

  • $ 3 500
  • Company report
  • June 2016
  • by Global Markets Direct

Fibroblast Growth Factor 2 (Basic Fibroblast Growth Factor or Heparin Binding Growth Factor 2 or FGF-2 or bFGF) - Pipeline Review, H1 2016 Summary Global Markets Direct’s, ‘Fibroblast Growth Facto ...

Interleukin 13 (IL13) - Pipeline Review, H1 2016

Interleukin 13 (IL13) - Pipeline Review, H1 2016

  • $ 3 500
  • Company report
  • June 2016
  • by Global Markets Direct

Interleukin 13 (IL13) - Pipeline Review, H1 2016 Summary Global Markets Direct’s, ‘Interleukin 13 (IL13) - Pipeline Review, H1 2016’, provides in depth analysis on Interleukin 13 (IL13) targeted ...

  • Industries : Biological Therapy
Stromal Cell Derived Factor 1 (C-X-C Motif Chemokine 12 or Intercrine Reduced in Hepatomas or SDF1 or Pre B cell Growth Stimulating Factor or CXCL12) - Pipeline Review, H1 2016

Stromal Cell Derived Factor 1 (C-X-C Motif Chemokine 12 or Intercrine Reduced in Hepatomas or SDF1 or Pre B cell Growth Stimulating Factor or CXCL12) - Pipeline Review, H1 2016

  • $ 3 500
  • Company report
  • June 2016
  • by Global Markets Direct

Stromal Cell Derived Factor 1 (C-X-C Motif Chemokine 12 or Intercrine Reduced in Hepatomas or SDF1 or Pre B cell Growth Stimulating Factor or CXCL12) - Pipeline Review, H1 2016 Summary Global Markets Direct’s, ...

  • Industries : Biological Therapy
Interleukin 2 (T Cell Growth Factor or Aldesleukin or IL2) - Pipeline Review, H1 2016

Interleukin 2 (T Cell Growth Factor or Aldesleukin or IL2) - Pipeline Review, H1 2016

  • $ 3 500
  • Company report
  • June 2016
  • by Global Markets Direct

Interleukin 2 (T Cell Growth Factor or Aldesleukin or IL2) - Pipeline Review, H1 2016 Summary Global Markets Direct’s, ‘Interleukin 2 (T Cell Growth Factor or Aldesleukin or IL2) - Pipeline Review, ...

  • Industries : Biological Therapy
C-X-C Chemokine Receptor Type 4 (Fusin or Leukocyte-Derived Seven Transmembrane Domain Receptor or Lipopolysaccharide-Associated Protein 3 or Stromal Cell-Derived Factor 1 Receptor or CD184 or CXCR4) - Pipeline Review, H1 2016

C-X-C Chemokine Receptor Type 4 (Fusin or Leukocyte-Derived Seven Transmembrane Domain Receptor or Lipopolysaccharide-Associated Protein 3 or Stromal Cell-Derived Factor 1 Receptor or CD184 or CXCR4) - Pipeline Review, H1 2016

  • $ 3 500
  • Company report
  • June 2016
  • by Global Markets Direct

C-X-C Chemokine Receptor Type 4 (Fusin or Leukocyte-Derived Seven Transmembrane Domain Receptor or Lipopolysaccharide-Associated Protein 3 or Stromal Cell-Derived Factor 1 Receptor or CD184 or CXCR4) - ...

  • Industries : Cancer, Pathology, Therapy, Biological Therapy
  • Countries : United States

ReportLinker simplifies how Analysts and Decision Makers get industry data for their business.